Aclaris Therapeutics, Inc. (ACRS): Shares Outstanding
120.50M
As of 2025-12-31
139.82M
As of 2026-06-30
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 120.50M | +11.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 107.85M | n/c | 2026-02-26, Balance as of period end |
| 2023-12-31 | 70.89M | +6.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 66.69M | +8.9% | 2024-02-27, Balance as of period end |
| 2021-12-31 | 61.23M | +35.7% | 2023-02-23, Balance as of period end |
| 2020-12-31 | 45.11M | +8.7% | 2022-02-24, Balance as of period end |
| 2019-12-31 | 41.49M | +0.7% | 2021-02-25, Balance as of period end |
| 2018-12-31 | 41.21M | +33.6% | 2020-02-25, Balance as of period end |
| 2017-12-31 | 30.86M | +18.4% | 2019-03-18, Balance as of period end |
| 2016-12-31 | 26.06M | +29.3% | 2018-03-12, Balance as of period end |
| 2015-12-31 | 20.16M | +638.3% | 2017-03-15, Balance as of period end |
| 2014-12-31 | 2.73M | n/a | 2016-03-23, Balance as of period end |